STOCK TITAN

embecta to Participate in Investor Events

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Embecta (NASDAQ: EMBC), a medical supplies company specializing in insulin delivery, has announced its participation in four major investor conferences in May and June 2025:

  • Goldman Sachs Leveraged Finance Conference (May 29) - One-on-one meetings in Dana Point, CA
  • Jefferies Global Healthcare Conference (June 5) - Fireside session at 4:55 PM EDT in NYC
  • Goldman Sachs Global Healthcare Conference (June 10) - Fireside session at 1:20 PM EDT in Miami
  • Truist Securities MedTech Conference (June 17) - One-on-one meetings in Boston
Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-6.31% News Effect

On the day this news was published, EMBC declined 6.31%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:

2025 Goldman Sachs Tenth Annual Leveraged Finance and Credit Conference

  • Management will host one-on-one investor meetings on Thursday, May 29, 2025, at Waldorf Astoria Monarch Beach Resort & Club, Dana Point, CA.

2025 Jefferies Global Healthcare Conference

  • Management will host a fireside session on Thursday, June 5, 2025, at 4:55 p.m. EDT, at the Marriott Marquis, New York City.

2025 Goldman Sachs 46th Annual Global Healthcare Conference

  • Management will host a fireside session on Tuesday, June 10, 2025, at 1:20 p.m. EDT, at the Loews Miami Beach Hotel, Miami, FL.

2025 Truist Securities MedTech Conference

  • Management will host one-on-one investor meetings on Tuesday, June 17, 2025, at the InterContinental, Boston, MA.

About embecta 
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts:

Media
Christian Glazar
Sr. Director, Corporate Communications
908-821-6922
Contact Media Relations
Investors
Pravesh Khandelwal
VP, Head of Investor Relations
551-264-6547
Contact IR

FAQ

What investor conferences will Embecta (EMBC) attend in 2025?

Embecta will attend four conferences: Goldman Sachs Leveraged Finance Conference (May 29), Jefferies Global Healthcare Conference (June 5), Goldman Sachs Global Healthcare Conference (June 10), and Truist Securities MedTech Conference (June 17).

When and where is Embecta's (EMBC) presentation at the 2025 Jefferies Global Healthcare Conference?

Embecta will host a fireside session at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 4:55 p.m. EDT at the Marriott Marquis in New York City.

What type of company is Embecta (EMBC)?

Embecta is a global medical supplies company with a 100-year legacy in insulin delivery, working to expand its presence in the broader medical supplies sector.

Which conferences will feature one-on-one investor meetings for Embecta (EMBC)?

Embecta will host one-on-one investor meetings at the Goldman Sachs Leveraged Finance Conference (May 29) and the Truist Securities MedTech Conference (June 17).
Embecta Corp

NASDAQ:EMBC

EMBC Rankings

EMBC Latest News

EMBC Latest SEC Filings

EMBC Stock Data

695.74M
58.35M
0.47%
101.61%
5.13%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
WILMINGTON